{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:29:17Z","timestamp":1792783757853,"version":"4.5.0"},"reference-count":186,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Stealth BioTherapeutics","award":["None"],"award-info":[{"award-number":["None"]}],"id":[{"id":"https:\/\/ror.org\/045frfm13","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Barth syndrome (BTHS) is a rare, X-linked recessive, infantile-onset debilitating disorder characterized by early-onset cardiomyopathy, skeletal muscle myopathy, growth delay, and neutropenia, with a worldwide incidence of 1\/300,000\u2013400,000 live births. The high mortality rate throughout infancy in BTHS patients is related primarily to progressive cardiomyopathy and a weakened immune system. BTHS is caused by defects in the TAZ gene that encodes tafazzin, a transacylase responsible for the remodeling and maturation of the mitochondrial phospholipid cardiolipin (CL), which is critical to normal mitochondrial structure and function (i.e., ATP generation). A deficiency in tafazzin results in up to a 95% reduction in levels of structurally mature CL. Because the heart is the most metabolically active organ in the body, with the highest mitochondrial content of any tissue, mitochondrial dysfunction plays a key role in the development of heart failure in patients with BTHS. Changes in mitochondrial oxidative phosphorylation reduce the ability of mitochondria to meet the ATP demands of the human heart as well as skeletal muscle, namely ATP synthesis does not match the rate of ATP consumption. The presence of several cardiomyopathic phenotypes have been described in BTHS, including dilated cardiomyopathy, left ventricular noncompaction, either alone or in conjunction with other cardiomyopathic phenotypes, endocardial fibroelastosis, hypertrophic cardiomyopathy, and an apical form of hypertrophic cardiomyopathy, among others, all of which can be directly attributed to the lack of CL synthesis, remodeling, and maturation with subsequent mitochondrial dysfunction. Several mechanisms by which these cardiomyopathic phenotypes exist have been proposed, thereby identifying potential targets for treatment. Dysfunction of the sarcoplasmic reticulum Ca\n                    <jats:sup>2+<\/jats:sup>\n                    -ATPase pump and inflammation potentially triggered by circulating mitochondrial components have been identified. Currently, treatment modalities are aimed at addressing symptomatology of HF in BTHS, but do not address the underlying pathology. One novel therapeutic approach includes elamipretide, which crosses the mitochondrial outer membrane to localize to the inner membrane where it associates with cardiolipin to enhance ATP synthesis in several organs, including the heart. Encouraging clinical results of the use of elamipretide in treating patients with BTHS support the potential use of this drug for management of this rare disease.\n                  <\/jats:p>","DOI":"10.1007\/s10741-020-10031-3","type":"journal-article","created":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T02:04:03Z","timestamp":1601517843000},"page":"237-253","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Barth syndrome cardiomyopathy: targeting the mitochondria with elamipretide"],"prefix":"10.1007","volume":"26","author":[{"given":"Hani N.","family":"Sabbah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,1]]},"reference":[{"key":"10031_CR1","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/cvr\/cvx014","volume":"113","author":"J Dubek","year":"2017","unstructured":"Dubek J, Maack C (2017) Barth syndrome cardiomyopathy. Cardiovasc Res 113:399\u2013410","journal-title":"Cardiovasc Res"},{"key":"10031_CR2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1750-1172-8-23","volume":"8","author":"SL Clarke","year":"2013","unstructured":"Clarke SL, Bowron A, Gonzalez IL, Groves SJ, Newbury-Ecob R, Clayton N, Martin RP, Tsai-Goodman B, Garratt V, Ashworth M, Bowen VM, McCurdy KR, Damin MK, Spencer CT, Toth MJ, Kelley RI, Steward CG (2013) Barth syndrome. Orphanet J Rare Dis 8:23","journal-title":"Orphanet J Rare Dis"},{"key":"10031_CR3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF01799418","volume":"19","author":"P Barth","year":"1996","unstructured":"Barth P, Van den Bogert C, Bolhuis P, Scholte H, van Gennip A, Schutgens R, Ketel A (1996) X-linked cardioskeletal myopathy and neutropenia (Barth syndrome): respiratory-chain abnormalities in cultured fibroblasts. J Inherit Metab Dis 19:157\u2013160","journal-title":"J Inherit Metab Dis"},{"key":"10031_CR4","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/ng0496-385","volume":"12","author":"S Bione","year":"1996","unstructured":"Bione S, D\u2019Adamo P, Maestrini E, Gedeon AK, Bolhuis PA, Toniolo D (1996) A novel X-linked gene, G4.5. is responsible for Barth syndrome. Nat Genet 12:385\u2013389","journal-title":"Nat Genet"},{"key":"10031_CR5","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/hmg\/dds447","volume":"22","author":"K Whited","year":"2013","unstructured":"Whited K, Baile MG, Currier P, Claypool SM (2013) Seven functional classes of Barth syndrome mutation. Hum Mol Genet 22:483\u2013492","journal-title":"Hum Mol Genet"},{"key":"10031_CR6","doi-asserted-by":"crossref","first-page":"51380","DOI":"10.1074\/jbc.M307382200","volume":"278","author":"Y Xu","year":"2003","unstructured":"Xu Y, Kelley RI, Blanck TJ, Schlame M (2003) Remodeling of cardiolipin by phospholipid transacylation. J Biol Chem 278:51380\u201351385","journal-title":"J Biol Chem"},{"key":"10031_CR7","doi-asserted-by":"crossref","first-page":"39217","DOI":"10.1074\/jbc.M606100200","volume":"281","author":"Y Xu","year":"2006","unstructured":"Xu Y, Malhotra A, Ren M, Schlame M (2006) The enzymatic function of tafazzin. J Biol Chem 281:39217\u201339224","journal-title":"J Biol Chem"},{"key":"10031_CR8","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1172\/JCI120849","volume":"128","author":"B Zhou","year":"2018","unstructured":"Zhou B, Tian R (2018) Mitochondrial dysfunction in pathophysiology of heart failure. J Clin Invest 128:3716\u20133726","journal-title":"J Clin Invest"},{"key":"10031_CR9","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nrcardio.2016.203","volume":"14","author":"DA Brown","year":"2017","unstructured":"Brown DA, Perry JB, Allen ME, Sabbah HN, Stauffer BL, Shaikh SR, Cleland JG, Colucci WS, Butler J, Voors AA, Anker SD, Pitt B, Pieske B, Filippatos G, Greene SJ, Gheorghiade M (2017) Expert consensus document: mitochondrial function as a therapeutic target in heart failure. Nat Rev Cardiol 14:238\u2013250","journal-title":"Nat Rev Cardiol"},{"key":"10031_CR10","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/0022-2828(92)93381-S","volume":"24","author":"E Barth","year":"1992","unstructured":"Barth E, Stammler G, Speiser B, Schaper J (1992) Ultrastructural quantitation of mitochondria and myofilaments in cardiac muscle from 10 different animal species including man. J Mol Cell Cardiol 24:669\u2013681","journal-title":"J Mol Cell Cardiol"},{"key":"10031_CR11","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1161\/01.RES.56.3.377","volume":"56","author":"J Schaper","year":"1985","unstructured":"Schaper J, Meiser E, Stammler G (1985) Ultrastructural morphometric analysis of myocardium from dogs, rats, hamsters, mice, and from human hearts. Circ Res 56:377\u2013391","journal-title":"Circ Res"},{"key":"10031_CR12","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.coph.2009.09.002","volume":"9","author":"DL Johannsen","year":"2009","unstructured":"Johannsen DL, Ravussin E (2009) The role of mitochondria in health and disease. Curr Opin Pharmacol 9:780\u2013786","journal-title":"Curr Opin Pharmacol"},{"key":"10031_CR13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/nrcardio.2014.189","volume":"12","author":"DO Okonko","year":"2015","unstructured":"Okonko DO, Shah AM (2015) Heart failure: mitochondrial dysfunction and oxidative stress in CHF. Nat Rev Cardiol 12:6\u20138","journal-title":"Nat Rev Cardiol"},{"key":"10031_CR14","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1080\/14779072.2016.1249466","volume":"14","author":"HN Sabbah","year":"2016","unstructured":"Sabbah HN (2016) Targeting mitochondrial dysfunction in the treatment of heart failure. Expert Rev Cardiovasc Ther 14:1305\u20131313","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10031_CR15","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1111\/bph.12468","volume":"171","author":"AV Birk","year":"2014","unstructured":"Birk AV, Chao WM, Bracken C, Warren JD, Szeto HH (2014) Targeting mitochondrial cardiolipin and the cytochrome c\/cardiolipin complex to promote electron transport and optimize mitochondrial ATP synthesis. Br J Pharmacol 171:2017\u20132028","journal-title":"Br J Pharmacol"},{"key":"10031_CR16","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJMra063052","volume":"356","author":"S Neubauer","year":"2007","unstructured":"Neubauer S (2007) The failing heart--an engine out of fuel. N Engl J Med 356:1140\u20131151","journal-title":"N Engl J Med"},{"key":"10031_CR17","first-page":"295","volume-title":"Fuels: Aerobic and anaerobic metabolism. The heart: physiology, from cell to circulation","author":"LH Opie","year":"1997","unstructured":"Opie LH (1997) Fuels: Aerobic and anaerobic metabolism. The heart: physiology, from cell to circulation, 3rd edn. Lippincott-Raven, Philadelphia, pp 295\u2013342","edition":"3"},{"key":"10031_CR18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10741-007-9079-1","volume":"13","author":"J Marin-Garcia","year":"2008","unstructured":"Marin-Garcia J, Goldenthal MJ (2008) Mitochondrial centrality in heart failure. Heart Fail Rev 13:137\u2013150","journal-title":"Heart Fail Rev"},{"key":"10031_CR19","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/ehf2.12408","volume":"6","author":"HN Sabbah","year":"2019","unstructured":"Sabbah HN, Gupta RC, Singh-Gupta V, Zhang K (2019) Effects of elamipretide on skeletal muscle in dogs with experimentally induced heart failure. ESC Heart Fail 6:328\u2013335","journal-title":"ESC Heart Fail"},{"key":"10031_CR20","doi-asserted-by":"crossref","first-page":"e13130","DOI":"10.14814\/phy2.13130","volume":"5","author":"A Bashir","year":"2017","unstructured":"Bashir A, Bohnert KL, Reeds DN, Peterson LR, Bittel AJ, de las Fuentes L, Pacak CA, Byrne BJ, Cade WT (2017) Impaired cardiac and skeletal muscle bioenergetics in children, adolescents, and young adults with Barth syndrome. Phys Rep 5:e13130","journal-title":"Phys Rep"},{"issue":"9","key":"10031_CR21","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1161\/CIRCRESAHA.113.302095","volume":"113","author":"SC Kolwicz Jr","year":"2013","unstructured":"Kolwicz SC Jr, Purohit S, Tian R (2013) Cardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes. Circ Res 113(9):603\u2013616","journal-title":"Circ Res"},{"key":"10031_CR22","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10741-016-9586-z","volume":"22","author":"SZ Liu","year":"2017","unstructured":"Liu SZ, Marcinek DJ (2017) Skeletal muscle bioenergetics in aging and heart failure. Heart Fail Rev 22:167\u2013178","journal-title":"Heart Fail Rev"},{"key":"10031_CR23","doi-asserted-by":"crossref","first-page":"H2122","DOI":"10.1152\/ajpheart.00479.2010","volume":"301","author":"CT Spencer","year":"2011","unstructured":"Spencer CT, Byrne BJ, Bryant RM, Margossian R, Maisenbacher M, Breitenger P, Benni PB, Redfearn S, Marcus E, Cade WT (2011) Impaired cardiac reserve and severely diminished skeletal muscle O(2) utilization mediate exercise intolerance in Barth syndrome. Am J Physiol Heart Circ Physiol 301:H2122\u2013H2129","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10031_CR24","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1089\/hum.2018.020","volume":"30","author":"S Suzuki-Hatano","year":"2019","unstructured":"Suzuki-Hatano S, Saha M, Rizzo SA, Witko RL, Gosiker BJ, Ramanathan M, Soustek MS, Jones MD, Kang PB, Byrne BJ, Cade WT, Pacak CA (2019) AAV-mediated TAZ gene replacement restores mitochondrial and cardioskeletal function in Barth syndrome. Hum Gene Ther 30:139\u2013154","journal-title":"Hum Gene Ther"},{"key":"10031_CR25","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.mgene.2015.04.001","volume":"4","author":"A Hijikata","year":"2015","unstructured":"Hijikata A, Yura K, Ohara O, Go M (2015) Structural and functional analyses of Barth syndrome-causing mutations and alternative splicing in the tafazzin acyltransferase domain. Meta Gene 4:92\u2013106","journal-title":"Meta Gene"},{"key":"10031_CR26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.yjmcc.2017.11.005","volume":"114","author":"AA Dinca","year":"2018","unstructured":"Dinca AA, Chien WM, Chin MT (2018) Identification of novel mitochondrial localization signals in human tafazzin, the cause of the inherited cardiomyopathic disorder Barth syndrome. J Mol Cell Cardiol 114:83\u201392","journal-title":"J Mol Cell Cardiol"},{"issue":"10","key":"10031_CR27","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/nchembio.1068","volume":"20128","author":"K Gawrisch","year":"2012","unstructured":"Gawrisch K (2012) Tafazzin senses curvature. Nat Chem Biol 20128(10):811\u2013812","journal-title":"Nat Chem Biol"},{"issue":"30","key":"10031_CR28","doi-asserted-by":"crossref","first-page":"15491","DOI":"10.1074\/jbc.M116.718510","volume":"291","author":"M Abe","year":"2016","unstructured":"Abe M, Hasegawa Y, Oku M, Sawada Y, Tanaka E, Sakai Y, Miyoshi H (2016) Mechanism for remodeling of the acyl chain composition of cardiolipin catalyzed by saccharomyces cerevisiae tafazzin. J Biol Chem 291(30):15491\u201315502","journal-title":"J Biol Chem"},{"key":"10031_CR29","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1128\/EC.00237-13","volume":"12","author":"JD Herndon","year":"2013","unstructured":"Herndon JD, Claypool SM, Koehler CM (2013) The Taz1p transacylase is imported and sorted into the outer mitochondrial membrane via a membrane anchor domain. Eukaryot Cell 12:1600\u20131608","journal-title":"Eukaryot Cell"},{"key":"10031_CR30","doi-asserted-by":"crossref","first-page":"26245","DOI":"10.1074\/jbc.M112.382036","volume":"287","author":"W Huang","year":"2012","unstructured":"Huang W, Lv X, Liu C, Zha Z, Zhang H, Jiang Y, Xiong Y, Lei QY, Guan KL (2012) The N-terminal phosphodegron targets TAZ\/WWTR1 protein for SCF\u03b2-TrCP-dependent degradation in response to phosphatidylinositol 3-kinase inhibition. J Biol Chem 287:26245\u201326253","journal-title":"J Biol Chem"},{"key":"10031_CR31","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3892\/ijo.2017.3998","volume":"51","author":"L Ge","year":"2017","unstructured":"Ge L, Li DS, Chen F, Feng JD, Li B, Wang TJ (2017) TAZ overexpression is associated with epithelial-mesenchymal transition in cisplatin-resistant gastric cancer cells. Int J Oncol 51:307\u2013315","journal-title":"Int J Oncol"},{"key":"10031_CR32","doi-asserted-by":"crossref","first-page":"e0177171","DOI":"10.1371\/journal.pone.0177171","volume":"12","author":"M Chen","year":"2017","unstructured":"Chen M, Zhang Y, Zheng PS (2017) Tafazzin (TAZ) promotes the tumorigenicity of cervical cancer cells and inhibits apoptosis. PLoS One 12:e0177171","journal-title":"PLoS One"},{"key":"10031_CR33","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10863-014-9591-7","volume":"48","author":"C Ye","year":"2016","unstructured":"Ye C, Shen Z, Greenberg ML (2016) Cardiolipin remodeling: a regulatory hub for modulating cardiolipin metabolism and function. J Bioenerg Biomembr 48:113\u2013123","journal-title":"J Bioenerg Biomembr"},{"key":"10031_CR34","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ymgme.2012.09.013","volume":"107","author":"D Ronvelia","year":"2012","unstructured":"Ronvelia D, Greenwood J, Platt J, Hakim S, Zaragoza MV (2012) Intrafamilial variability for novel TAZ gene mutation: Barth syndrome with dilated cardiomyopathy and heart failure in an infant and left ventricular noncompaction in his great-uncle. Mol Genet Metab 107:428\u2013432","journal-title":"Mol Genet Metab"},{"key":"10031_CR35","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11745-016-4229-7","volume":"52","author":"N Ikon","year":"2017","unstructured":"Ikon N, Ryan RO (2017) Barth syndrome: connecting cardiolipin to cardiomyopathy. Lipids 52:99\u2013108","journal-title":"Lipids"},{"key":"10031_CR36","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1007\/s00018-008-8030-5","volume":"65","author":"RH Houtkooper","year":"2008","unstructured":"Houtkooper RH, Vaz FM (2008) Cardiolipin, the heart of mitochondrial metabolism. Cell Mol Life Sci 65:2493\u20132506","journal-title":"Cell Mol Life Sci"},{"key":"10031_CR37","first-page":"321","volume":"1791","author":"M Schlame","year":"2009","unstructured":"Schlame M (2009) Formation of molecular species of mitochondrial cardiolipin 2. A mathematical model of pattern formation by phospholipid transacylation. Biochem Biophys Acta 1791:321\u2013325","journal-title":"Biochem Biophys Acta"},{"key":"10031_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.chemphyslip.2015.09.005","volume":"193","author":"GJ Gaspard","year":"2015","unstructured":"Gaspard GJ, McMaster CR (2015) Cardiolipin metabolism and its causal role in the etiology of the inherited cardiomyopathy Barth syndrome. Chem Phys Lipids 193:1\u201310","journal-title":"Chem Phys Lipids"},{"key":"10031_CR39","doi-asserted-by":"crossref","first-page":"31727","DOI":"10.1074\/jbc.M402930200","volume":"279","author":"J Cao","year":"2004","unstructured":"Cao J, Liu Y, Lockwood J, Burn P, Shi Y (2004) A novel cardiolipin-remodeling pathway revealed by a gene encoding an endoplasmic reticulum-associated acyl-CoA:lysocardiolipin acyltransferase (ALCAT1) in mouse. J Biol Chem 279:31727\u201331734","journal-title":"J Biol Chem"},{"key":"10031_CR40","doi-asserted-by":"crossref","first-page":"30360","DOI":"10.1074\/jbc.M109.048322","volume":"284","author":"WA Taylor","year":"2009","unstructured":"Taylor WA, Hatch GM (2009) Identification of the human mitochondrial linoleoyl-coenzyme a monolysocardiolipin acyltransferase (MLCLAT-1). J Biol Chem 284:30360\u201330371","journal-title":"J Biol Chem"},{"key":"10031_CR41","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2174\/1871529X14666140505123753","volume":"14","author":"EM Mejia","year":"2014","unstructured":"Mejia EM, Cole LK, Hatch GM (2014) Cardiolipin metabolism and the role it plays in heart failure and mitochondrial supercomplex formation. Cardiovasc Hematol Disord Drug Targets 14:98\u2013106","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"key":"10031_CR42","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s11745-008-3197-y","volume":"43","author":"MA Kiebish","year":"2008","unstructured":"Kiebish MA, Han X, Cheng H, Chuang JH, Seyfried TN (2008) Brain mitochondrial lipid abnormalities in mice susceptible to spontaneous gliomas. Lipids. 43:951\u2013959","journal-title":"Lipids."},{"key":"10031_CR43","doi-asserted-by":"crossref","first-page":"5450","DOI":"10.1016\/j.febslet.2006.07.022","volume":"580","author":"M Schlame","year":"2006","unstructured":"Schlame M, Ren M (2006) Barth syndrome, a human disorder of cardiolipin metabolism. FEBS Lett 580:5450\u20135455","journal-title":"FEBS Lett"},{"key":"10031_CR44","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.plipres.2005.12.001","volume":"45","author":"KD Hauff","year":"2006","unstructured":"Hauff KD, Hatch GM (2006) Cardiolipin metabolism and Barth syndrome. Prog Lipid Res 45:91\u2013101","journal-title":"Prog Lipid Res"},{"key":"10031_CR45","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1194\/jlr.R700018-JLR200","volume":"49","author":"M Schlame","year":"2008","unstructured":"Schlame M (2008) Cardiolipin synthesis for the assembly of bacterial and mitochondrial membranes. J Lipid Res 49:1607\u20131620","journal-title":"J Lipid Res"},{"key":"10031_CR46","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.chemphyslip.2005.08.002","volume":"138","author":"M Schlame","year":"2005","unstructured":"Schlame M, Ren M, Xu Y, Greenberg ML, Haller I (2005) Molecular symmetry in mitochondrial cardiolipins. Chem Phys Lipids 138:38\u201349","journal-title":"Chem Phys Lipids"},{"key":"10031_CR47","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/j.jacc.2003.06.015","volume":"42","author":"M Schlame","year":"2003","unstructured":"Schlame M, Kelley RI, Feigenbaum A, Towbin JA, Heerdt PM, Schieble T, Wanders RJ, DiMauro S, Blanck TJ (2003) Phospholipid abnormalities in children with Barth syndrome. J Am Coll Cardiol 42:1994\u20131999","journal-title":"J Am Coll Cardiol"},{"key":"10031_CR48","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.cell.2009.08.005","volume":"138","author":"A Chacinska","year":"2009","unstructured":"Chacinska A, Koehler CM, Milenkovic D, Lithgow T, Pfanner N (2009) Importing mitochondrial proteins: machineries and mechanisms. Cell 138:628\u2013644","journal-title":"Cell"},{"key":"10031_CR49","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1146\/annurev.biochem.76.052705.163409","volume":"76","author":"W Neupert","year":"2007","unstructured":"Neupert W, Herrmann JM (2007) Translocation of proteins into mitochondria. Annu Rev Biochem 76:723\u2013749","journal-title":"Annu Rev Biochem"},{"key":"10031_CR50","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/labinvest.3780427","volume":"82","author":"JJ Bissler","year":"2002","unstructured":"Bissler JJ, Tsoras M, G\u00f6ring HHH, Hug P, Chuck G, Tombragel E, McGraw C, Schlotman J, Ralston MA, Hug G (2002) Infantile dilated X-linked cardiomyopathy, G4.5 mutations, altered lipids, and ultrastructural malformations of mitochondria in heart, liver, and skeletal muscle. Lab Investig 82:335\u2013344","journal-title":"Lab Investig"},{"key":"10031_CR51","unstructured":"Haines TH, Dencher NA (2002) Cardiolipin: a proton trap for oxidative phosphorylation. FEBS Lett:52835\u201352839"},{"key":"10031_CR52","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/0006-291X(80)90622-1","volume":"93","author":"M Fry","year":"1980","unstructured":"Fry M, Green DE (1980) Cardiolipin requirement by cytochrome oxidase and the catalytic role of phospholipid. Biochem Biophys Res Commun 93:1238\u20131246","journal-title":"Biochem Biophys Res Commun"},{"key":"10031_CR53","doi-asserted-by":"crossref","first-page":"9967","DOI":"10.1016\/S0021-9258(18)43487-4","volume":"255","author":"M Fry","year":"1980","unstructured":"Fry M, Blondin GA, Green DE (1980) The localization of tightly bound cardiolipin in cytochrome oxidase. J Biol Chem 255:9967\u20139970","journal-title":"J Biol Chem"},{"key":"10031_CR54","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1016\/S0021-9258(19)69888-1","volume":"256","author":"M Fry","year":"1981","unstructured":"Fry M, Green DE (1981) Cardiolipin requirement for electron transfer in complex I and III of the mitochondrial respiratory chain. J Biol Chem 256:1874\u20131880","journal-title":"J Biol Chem"},{"key":"10031_CR55","doi-asserted-by":"crossref","first-page":"C33","DOI":"10.1152\/ajpcell.00243.2006","volume":"292","author":"AJ Chicco","year":"2007","unstructured":"Chicco AJ, Sparagna GC (2007) Role of cardiolipin alterations in mitochondrial dysfunction and disease. Am J Phys Cell Physiol 292:C33\u2013C44","journal-title":"Am J Phys Cell Physiol"},{"key":"10031_CR56","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0304-4157(92)90035-9","volume":"1113","author":"FL Hoch","year":"1992","unstructured":"Hoch FL (1992) Cardiolipins and biomembrane function. Biochim Biophys Acta 1113:71\u2013133","journal-title":"Biochim Biophys Acta"},{"key":"10031_CR57","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jmb.2006.06.057","volume":"361","author":"M McKenzie","year":"2006","unstructured":"McKenzie M, Lazarou M, Thorburn DR, Ryan MT (2006) Mitochondrial respiratory chain supercomplexes are destabilized in Barth syndrome patients. J Mol Biol 361:462\u2013469","journal-title":"J Mol Biol"},{"key":"10031_CR58","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1038\/sj.emboj.7601618","volume":"26","author":"K Shinzawa-Itoh","year":"2007","unstructured":"Shinzawa-Itoh K, Aoyama H, Muramoto K, Terada H, Kurauchi T, Tadehara Y, Yamasaki A, Sugimura T, Kurono S, Tsujimoto K, Mizushima T, Yamashita E, Tsukihara T, Yoshikawa S (2007) Structures and physiological roles of 13 integral lipids of bovine heart cytochrome c oxidase. EMBO J 26:1713\u20131725","journal-title":"EMBO J"},{"key":"10031_CR59","doi-asserted-by":"crossref","first-page":"43553","DOI":"10.1074\/jbc.C200551200","volume":"277","author":"M Zhang","year":"2002","unstructured":"Zhang M, Mileykovskaya E, Dowhan W (2002) Gluing the respiratory chain together. Cardiolipin is required for supercomplex formation in the inner mitochondrial membrane. J Biol Chem 277:43553\u201343556","journal-title":"J Biol Chem"},{"key":"10031_CR60","doi-asserted-by":"crossref","first-page":"52873","DOI":"10.1074\/jbc.M308366200","volume":"278","author":"K Pfeiffer","year":"2003","unstructured":"Pfeiffer K, Gohil V, Stuart RA, Hunte C, Brandt U, Greenberg ML, Schagger H (2003) Cardiolipin stabilizes respiratory chain supercomplexes. J Biol Chem 278:52873\u201352880","journal-title":"J Biol Chem"},{"key":"10031_CR61","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1023\/A:1020576315771","volume":"30","author":"FL Hoch","year":"1998","unstructured":"Hoch FL (1998) Cardiolipins and mitochondrial proton-selective leakage. J Bioenerg Biomembr 30:511\u2013532","journal-title":"J Bioenerg Biomembr"},{"key":"10031_CR62","doi-asserted-by":"crossref","first-page":"R465","DOI":"10.1016\/S0960-9822(06)00237-5","volume":"7","author":"AF Neuwald","year":"1997","unstructured":"Neuwald AF (1997) Barth syndrome may be due to an acyltransferase deficiency. Curr Biol 7:R465\u2013R466","journal-title":"Curr Biol"},{"key":"10031_CR63","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/j.bbamem.2009.07.009","volume":"1788","author":"RH Houtkooper","year":"2009","unstructured":"Houtkooper RH, Turkenburg M, Poll-The BT, Karall D, P\u00e9rez-Cerd\u00e1 C, Morrone A, Malvagia S, Wanders RJ, Kulik W, Vaz FM (2009) The enigmatic role of tafazzin in cardiolipin metabolism. Biochim Biophys Acta 1788:2003\u20132014","journal-title":"Biochim Biophys Acta"},{"key":"10031_CR64","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1194\/jlr.M800561-JLR200","volume":"50","author":"HK Saini-Chohan","year":"2009","unstructured":"Saini-Chohan HK, Holmes MG, Chicco AJ, Taylor WA, Moore RL, McCune SA, Hickson-Bick DL, Hatch GM, Sparagna GC (2009) Cardiolipin biosynthesis and remodeling enzymes are altered during development of heart failure. J Lipid Res 50:1600\u20131608","journal-title":"J Lipid Res"},{"key":"10031_CR65","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1194\/jlr.M500056-JLR200","volume":"46","author":"F Valianpour","year":"2005","unstructured":"Valianpour F, Mitsakos V, Schlemmer D, Towbin JA, Taylor JM, Ekert PG, Thorburn DR, Munnich A, Wanders RJ, Barth PG, Vaz FM (2005) Monolysocardiolipins accumulate in Barth syndrome but do not lead to enhanced apoptosis. J Lipid Res 46:1182\u20131195","journal-title":"J Lipid Res"},{"key":"10031_CR66","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/nm.3545","volume":"20","author":"G Wang","year":"2014","unstructured":"Wang G, McCain ML, Yang L, He A, Pasqualini FS, Agarwal A et al (2014) Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies. Nat Med 20:616\u2013623","journal-title":"Nat Med"},{"key":"10031_CR67","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(09)62023-7","volume":"375","author":"JL Jefferies","year":"2010","unstructured":"Jefferies JL, Towbin JA (2010) Dilated cardiomyopathy. Lancet. 375:752\u2013762","journal-title":"Lancet."},{"issue":"2","key":"10031_CR68","doi-asserted-by":"crossref","first-page":"e337","DOI":"10.1542\/peds.2005-2667","volume":"118","author":"CT Spencer","year":"2006","unstructured":"Spencer CT, Bryant RM, Day J et al (2006) Cardiac and clinical phenotype in Barth syndrome. Pediatrics. 118(2):e337\u2013e346","journal-title":"Pediatrics."},{"key":"10031_CR69","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ajmg.1320450309","volume":"45","author":"LC Ades","year":"1993","unstructured":"Ades LC, Gedeon AK, Wilson MJ, Latham M, Partington MW, Mulley JC, Nelson J, Lui K, Sillence DO (1993) Barth syndrome: clinical features and confirmation of gene localisation to distal Xq28. Am J Med Genet 45:327\u2013334","journal-title":"Am J Med Genet"},{"key":"10031_CR70","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1086\/514879","volume":"61","author":"SB Bleyl","year":"1997","unstructured":"Bleyl SB, Mumford BR, Thompson V, Carey JC, Pysher TJ, Chin TK, Ward K (1997) Neonatal, lethal noncompaction of the left ventricular myocardium is allelic with Barth syndrome. Am J Hum Genet 61:868\u2013872","journal-title":"Am J Hum Genet"},{"key":"10031_CR71","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/ajmg.c.31372","volume":"163","author":"JL Jefferies","year":"2013","unstructured":"Jefferies JL (2013) Barth syndrome. Am J Med Genet C: Semin Med Genet 163:198\u2013205","journal-title":"Am J Med Genet C: Semin Med Genet"},{"key":"10031_CR72","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/415227a","volume":"415","author":"JA Towbin","year":"2002","unstructured":"Towbin JA, Bowles NE (2002) The failing heart. Nature. 415:227\u2013233","journal-title":"Nature."},{"key":"10031_CR73","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1161\/01.CIR.0000100664.10777.B8","volume":"108","author":"RH Pignatelli","year":"2003","unstructured":"Pignatelli RH, McMahon CJ, Dreyer WJ, Denfield SW, Price J, Belmont JW, Craigen WJ, Wu J, El Said H, Bezold LI, Clunie S, Fernbach S, Bowles NE, Towbin JA (2003) Clinical characterization of left ventricular noncompaction in children: a relatively common form of cardiomyopathy. Circulation. 108:2672\u20132678","journal-title":"Circulation."},{"key":"10031_CR74","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1161\/CIRCULATIONAHA.107.746164","volume":"117","author":"S Klaassen","year":"2008","unstructured":"Klaassen S, Probst S, Oechslin E, Gerull B, Krings G, Schuler P, Greutmann M, Hurlimann D, Yegitbasi M, Pons L, Gramlich M, Drenckhahn JD, Heuser A, Berger F, Jenni R, Thierfelder L (2008) Mutations in sarcomere protein genes in left ventricular noncompaction. Circulation. 117:2893\u20132901","journal-title":"Circulation."},{"key":"10031_CR75","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1161\/CIR.0b013e318223e230","volume":"124","author":"BJ Gersh","year":"2011","unstructured":"Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rakowski H, Seidman CE, Towbin JA, Udelson JE, Yancy CW, American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines; American Association for Thoracic Surgery; American Society of Echocardiography; American Society of Nuclear Cardiology; Heart Failure Society of America; Heart Rhythm Society; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons (2011) 2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Circulation. 124:2761\u20132796","journal-title":"Circulation."},{"key":"10031_CR76","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1161\/CIRCULATIONAHA.113.002511","volume":"127","author":"ST Brescia","year":"2013","unstructured":"Brescia ST, Rossano JW, Pignatelli R, Jefferies JL, Price JF, Decker JA, Denfield SW, Dreyer WJ, Smith O, Towbin JA, Kim JJ (2013) Mortality and sudden death in pediatric left ventricular noncompaction in a tertiary referral center. Circulation. 127:2202\u20132208","journal-title":"Circulation."},{"key":"10031_CR77","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3109\/07853890008998837","volume":"32","author":"K Frank","year":"2000","unstructured":"Frank K, Kranias EG (2000) Phospholamban and cardiac contractility. Ann Med 32:572\u2013578","journal-title":"Ann Med"},{"key":"10031_CR78","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nrm1151","volume":"4","author":"DH MacLennan","year":"2003","unstructured":"MacLennan DH, Kranias EG (2003) Phospholamban: a crucial regulator of cardiac contractility. Nat Rev Mol Cell Biol 4:566\u2013577","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10031_CR79","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1152\/japplphysiol.00529.2007","volume":"103","author":"AR Tupling","year":"2007","unstructured":"Tupling AR, Vigna C, Ford RJ, Tsuchiya SC, Graham DA, Denniss SG, Rush JW (2007) Effects of buthionine sulfoximine treatment on diaphragm contractility and SR Ca2+ pump function in rats. J Appl Physiol (1985) 103:1921\u20131928","journal-title":"J Appl Physiol (1985)"},{"key":"10031_CR80","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/0014-5793(95)01530-2","volume":"379","author":"RI Viner","year":"1996","unstructured":"Viner RI, Ferrington DA, Huhmer AF, Bigelow DJ, Schoneich C (1996) Accumulation of nitrotyrosine on the SERCA2a isoform of SR Ca-ATPase of rat skeletal muscle during aging: a peroxynitrite-mediated process? FEBS Lett 379:286\u2013290","journal-title":"FEBS Lett"},{"key":"10031_CR81","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/0014-5793(95)01530-2","volume":"379","author":"RI Viner","year":"1999","unstructured":"Viner RI, Williams TD, Sch\u00f6neich C (1999) Peroxynitrite modification of protein thiols: oxidation, nitrosylation, and S-Glutathiolation of functionally important cysteine residue(s) in the sarcoplasmic reticulum Ca2+ -ATPase. FEBS Lett 379:286\u2013290","journal-title":"FEBS Lett"},{"key":"10031_CR82","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1152\/physrev.00029.2006","volume":"87","author":"P Pacher","year":"2007","unstructured":"Pacher P, Beckman JS, Liaudet L (2007) Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87:315\u2013424","journal-title":"Physiol Rev"},{"issue":"2","key":"10031_CR83","doi-asserted-by":"crossref","first-page":"jah3-e000455","DOI":"10.1161\/JAHA.111.000455","volume":"1","author":"CK Phoon","year":"2012","unstructured":"Phoon CK, Acehan D, Schlame M, Stokes DL, Edelman-Novemsky I, Yu D, Xu Y, Viswanathan N, Ren M (2012) Tafazzin knockdown in mice leads to a developmental cardiomyopathy with early diastolic dysfunction preceding myocardial noncompaction. J Am Heart Assoc 1(2):jah3-e000455","journal-title":"J Am Heart Assoc"},{"key":"10031_CR84","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3389\/fphys.2013.00074","volume":"4","author":"C Powers","year":"2013","unstructured":"Powers C, Huang Y, Strauss AW, Khuchua Z (2013) Diminished exercise capacity and mitochondrial bc1 complex deficiency in tafazzin-knockdown mice. Front Physiol 4:74","journal-title":"Front Physiol"},{"key":"10031_CR85","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S0022-3476(05)80289-6","volume":"119","author":"RI Kelley","year":"1991","unstructured":"Kelley RI, Cheatham JP, Clark BJ, Nigro MA, Powell BR, Sherwood GW, Sladky JT, Swisher WP (1991) X-linked dilated cardiomyopathy with neutropenia, growth retardation, and 3-methylglutaconic aciduria. J Pediatr 119:738\u2013747","journal-title":"J Pediatr"},{"key":"10031_CR86","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1161\/01.CIR.0000156461.81529.D7","volume":"111","author":"AJ Lokuta","year":"2005","unstructured":"Lokuta AJ, Maertz NA, Meethal SV, Potter KT, Kamp TJ, Valdivia HH, Haworth RA (2005) Increased nitration of sarcoplasmic reticulum Ca2+-ATPase in human heart failure. Circulation 111:988\u2013995","journal-title":"Circulation"},{"key":"10031_CR87","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1074\/jbc.M110.171439","volume":"286","author":"D Acehan","year":"2011","unstructured":"Acehan D, Vaz F, Houtkooper RH, James J, Moore V, Tokunaga C, Kulik W, Wansapura J, Toth MJ, Strauss A, Khuchua Z (2011) Cardiac and skeletal muscle defects in a mouse model of human Barth syndrome. J Biol Chem 286:899\u2013908","journal-title":"J Biol Chem"},{"key":"10031_CR88","first-page":"e14215","volume":"7","author":"JL Braun","year":"2019","unstructured":"Braun JL, Hamstra SI, Messner HN, Fajardo VA (2019) SERCA2a tyrosine nitration coincides with impairments in maximal SERCA activity in left ventricles from tafazzin-deficient mice. Phys Rep 7:e14215","journal-title":"Phys Rep"},{"key":"10031_CR89","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0735-1097(99)00170-9","volume":"34","author":"F Ichida","year":"1999","unstructured":"Ichida F, Hamamichi Y, Miyawaki T, Ono Y, Kamiya T, Akagi T, Hamada H, Hirose O, Isobe T, Yamada K, Kurotobi S, Mito H, Miyake T, Murakami Y, Nishi T, Shinohara M, Seguchi M, Tashiro S, Tomimatsu H (1999) Clinical features of isolated noncompaction of the ventricular myocardium: long-term clinical course, hemodynamic properties, and genetic background. J Am Coll Cardiol 34:233\u2013240","journal-title":"J Am Coll Cardiol"},{"key":"10031_CR90","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1161\/01.RES.0000100389.57520.1A","volume":"93","author":"T Ishiwata","year":"2003","unstructured":"Ishiwata T, Nakazawa M, Pu WT, Tevosian SG, Izumo S (2003) Developmental changes in ventricular diastolic function correlate with changes in ventricular myoarchitecture in normal mouse embryos. Circ Res 93:857\u2013865","journal-title":"Circ Res"},{"key":"10031_CR91","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/AIA.0b013e318034194e","volume":"45","author":"JM Zhang","year":"2007","unstructured":"Zhang JM, An J (2007) Cytokines, inflammation, and pain. Internl Anesth Clin 45:27\u201337","journal-title":"Internl Anesth Clin"},{"key":"10031_CR92","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0002-9149(98)00872-8","volume":"83","author":"P Aukrust","year":"1999","unstructured":"Aukrust P, Ueland T, Lien E, Bendtzen K, Muller F, Andreassen AK, Nord\u00f8y I, Aass H, Espevik T, Simonsen S, Fr\u00f8land SS, Gullestad L (1999) Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 83:376\u2013382","journal-title":"Am J Cardiol"},{"key":"10031_CR93","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S0735-1097(96)00268-9","volume":"28","author":"M Testa","year":"1996","unstructured":"Testa M, Yeh M, Lee P, Fanelli R, Loperfido F, Berman JW, LeJemtel T (1996) Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. J Am Coll Cardiol 28:964\u2013971","journal-title":"J Am Coll Cardiol"},{"key":"10031_CR94","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/0735-1097(95)00589-7","volume":"27","author":"G Torre-Amione","year":"1996","unstructured":"Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL (1996) Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 27:1201\u20131206","journal-title":"J Am Coll Cardiol"},{"key":"10031_CR95","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1161\/01.CIR.97.14.1382","volume":"97","author":"B Bozkurt","year":"1998","unstructured":"Bozkurt B, Kribbs SB, Clubb FJ, Michael LH, Didenko VV, Hornsby PJ, Seta Y, Oral H, Spinale FG, Mann DL (1998) Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive dysfunction and remodelling in rats. Circulation 97:1382\u20131391","journal-title":"Circulation"},{"key":"10031_CR96","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1161\/01.RES.81.4.627","volume":"81","author":"T Kubota","year":"1997","unstructured":"Kubota T, McTernan CF, Frye CS, Slawson SE, Lemster BH, Koretsky AP, Demetris AJ, Feldman AM (1997) Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha. Circ Res 81:627\u2013635","journal-title":"Circ Res"},{"issue":"suppl 1","key":"10031_CR97","doi-asserted-by":"crossref","first-page":"S414","DOI":"10.1038\/bjp.2008.1","volume":"153","author":"P Fischer","year":"2008","unstructured":"Fischer P, Hilfiker-Kleiner D (2008) Role of gp130- mediated signalling pathways in the heart and its impact on potential therapeutic aspects. Br J Pharmacol 153(suppl 1):S414\u2013S427","journal-title":"Br J Pharmacol"},{"key":"10031_CR98","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1161\/01.RES.0000043825.01705.1B","volume":"91","author":"DL Mann","year":"2002","unstructured":"Mann DL (2002) Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res 91:988\u2013998","journal-title":"Circ Res"},{"key":"10031_CR99","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1464-5491.2010.03221.x","volume":"28","author":"W Dinh","year":"2011","unstructured":"Dinh W, Futh R, Nickl W, Krahn T, Ellinghaus P, Scheffold T, Bansemir L, Bufe A, Barroso MC, Lankisch M (2011) Elevated plasma levels of TNF-alpha and interleukin-6 in patients with diastolic dysfunction and glucose metabolism disorders. Diabet Med 28:311\u2013318","journal-title":"Diabet Med"},{"key":"10031_CR100","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s12012-010-9078-7","volume":"10","author":"S Zibadi","year":"2010","unstructured":"Zibadi S, Vazquez R, Larson DF, Watson RR (2010) T-lymphocyte regulation of lysyl oxidase in diet-induced cardiac fibrosis. Cardiovasc Toxicol 10:190\u2013198","journal-title":"Cardiovasc Toxicol"},{"issue":"1","key":"10031_CR101","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1476-9255-9-25","volume":"9","author":"LD Wilson","year":"2012","unstructured":"Wilson LD, Al-Majid S, Rakovski CS, Schwindt CD (2012) Higher IL-6 and IL6:IGF ratio in patients with Barth syndrome. J Inflamm 9(1):25","journal-title":"J Inflamm"},{"key":"10031_CR102","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.metabol.2006.08.025","volume":"56","author":"CH Lang","year":"2007","unstructured":"Lang CH, Frost RA (2007) Sepsis-induced suppression of skeletal muscle translation initiation mediated by tumor necrosis factor alpha. Metabolism. 56:49\u201357","journal-title":"Metabolism."},{"key":"10031_CR103","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF00926829","volume":"125","author":"C Garcia-Martinez","year":"1993","unstructured":"Garcia-Martinez C, Lopez-Soriano FJ, Argiles JM (1993) Acute treatment with tumour necrosis factor-alpha induces changes in protein metabolism in rat skeletal muscle. Mol Cell Biochem 125:11\u201318","journal-title":"Mol Cell Biochem"},{"key":"10031_CR104","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1161\/01.CIR.0000156469.96135.0D","volume":"111","author":"SP Janssen","year":"2005","unstructured":"Janssen SP, Gayan-Ramirez G, Van den Bergh A, Herijgers P, Maes K, Verbeken E, Decramer M (2005) Interleukin-6 causes myocardial failure and skeletal muscle atrophy in rats. Circulation. 111:996\u20131005","journal-title":"Circulation."},{"key":"10031_CR105","doi-asserted-by":"crossref","first-page":"E453","DOI":"10.1152\/ajpendo.00204.2007","volume":"293","author":"CH Lang","year":"2007","unstructured":"Lang CH, Frost RA, Vary TC (2007) Regulation of muscle protein synthesis during sepsis and inflammation. Am J Physiol Endocrinol Metab 293:E453\u2013E459","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10031_CR106","first-page":"E977","volume":"269","author":"CV Jurasinski","year":"1995","unstructured":"Jurasinski CV, Vary TC (1995) Insulin-like growth factor I accelerates protein synthesis in skeletal muscle during sepsis. Am J Phys 269:E977\u2013E981","journal-title":"Am J Phys"},{"key":"10031_CR107","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/j.1440-1681.2007.04868.x","volume":"35","author":"MD Grounds","year":"2008","unstructured":"Grounds MD, Radley HG, Gebski BL, Bogoyevitch MA, Shavlakadze T (2008) Implications of cross-talk between tumour necrosis factor and insulin-like growth factor-1 signalling in skeletal muscle. Clin Exp Pharmacol Physiol 35:846\u2013851","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10031_CR108","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3389\/fimmu.2018.00832","volume":"9","author":"S Grazioli","year":"2018","unstructured":"Grazioli S, Pugin J (2018) Mitochondrial damage-associated molecular patterns: from inflammatory signaling to human diseases. Front Immunol 9:832","journal-title":"Front Immunol"},{"key":"10031_CR109","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1042\/BCJ20170714","volume":"475","author":"H Nakayama","year":"2018","unstructured":"Nakayama H, Otsu K (2018) Mitochondrial DNA as an inflammatory mediator in cardiovascular diseases. Biochem J 475:839\u2013852","journal-title":"Biochem J"},{"key":"10031_CR110","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1189\/jlb.0703328","volume":"75","author":"LV Collins","year":"2004","unstructured":"Collins LV, Hajizadeh S, Holme E, Jonsson IM, Tarkowski A (2004) Endogenously oxidized mitochondrial DNA induces in vivo and in vitro inflammatory responses. J Leukoc Biol 75:995\u20131000","journal-title":"J Leukoc Biol"},{"key":"10031_CR111","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature08780","volume":"464","author":"Q Zhang","year":"2010","unstructured":"Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W et al (2010) Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464:104\u2013107","journal-title":"Nature"},{"key":"10031_CR112","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1042\/bj2490495","volume":"249","author":"MC Peitsch","year":"1988","unstructured":"Peitsch MC, Tschopp J, Kress A, Isliker H (1988) Antibody-independent activation of the complement system by mitochondria is mediated by cardiolipin. Biochem J 249:495\u2013500","journal-title":"Biochem J"},{"key":"10031_CR113","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/nri2873","volume":"10","author":"GY Chen","year":"2010","unstructured":"Chen GY, Nu\u00f1ez G (2010) Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol 10:826\u2013837","journal-title":"Nat Rev Immunol"},{"key":"10031_CR114","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nri.2017.21","volume":"17","author":"AP West","year":"2017","unstructured":"West AP, Shadel GS (2017) Mitochondrial DNA in innate immune responses and inflammatory pathology. Nat Rev Immunol 17:363\u2013375","journal-title":"Nat Rev Immunol"},{"key":"10031_CR115","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3233\/JAD-2012-120145","volume":"30","author":"A Mathew","year":"2012","unstructured":"Mathew A, Lindsley TA, Sheridan A, Bhoiwala DL, Hushmendy SF, Yager EJ et al (2012) Degraded mitochondrial DNA is a newly identified subtype of the damage associated molecular pattern (DAMP) family and possible trigger of neurodegeneration. J Alzheimers Dis 30:617\u2013627","journal-title":"J Alzheimers Dis"},{"key":"10031_CR116","unstructured":"Barth Syndrome Foundation. The Voice of the Patient: Barth Syndrome. Externally-Led Public Meeting: July 18, 2018. Report Date: March 8, 2019"},{"key":"10031_CR117","first-page":"88","volume":"5","author":"HN Sabbah","year":"2020","unstructured":"Sabbah HN (2020) Targeting the mitochondria in heart failure: a translational perspective. JACC 5:88\u2013106","journal-title":"JACC"},{"key":"10031_CR118","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1161\/01.CIR.87.5.1729","volume":"87","author":"HN Sabbah","year":"1993","unstructured":"Sabbah HN, Hansen-Smith F, Sharov VG, Kono T, Lesch M, Gengo PJ, Steffen RP, Levine TB, Goldstein S (1993) Decreased proportion of type I myofibers in skeletal muscle of dogs with chronic heart failure. Circulation 87:1729\u20131737","journal-title":"Circulation"},{"key":"10031_CR119","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1161\/01.CIR.81.2.518","volume":"81","author":"MJ Sullivan","year":"1990","unstructured":"Sullivan MJ, Green HJ, Cobb FR (1990) Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure. Circulation 81:518\u2013527","journal-title":"Circulation"},{"key":"10031_CR120","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0735-1097(97)00015-6","volume":"29","author":"R Hambrecht","year":"1997","unstructured":"Hambrecht R, Fiehn E, Yu J, Niebauer J, Weigl C, Hilbrich L, Adams V, Riede U, Schuler G (1997) Effects of endurance training on mitochondrial ultrastructure and fiber type distribution in skeletal muscle of patients with stable chronic heart failure. J Am Coll Cardiol 29:1067\u20131073","journal-title":"J Am Coll Cardiol"},{"key":"10031_CR121","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/00005768-199707000-00004","volume":"29","author":"MJ Sullivan","year":"1997","unstructured":"Sullivan MJ, Duscha BD, Klitgaard H, Kraus WE, Cobb FR, Saltin B (1997) Altered expression of myosin heavy chain in human skeletal muscle in chronic heart failure. Med Sci Sports Exerc 29:860\u2013866","journal-title":"Med Sci Sports Exerc"},{"key":"10031_CR122","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1113\/jphysiol.2005.097782","volume":"569","author":"DJ Marcinek","year":"2005","unstructured":"Marcinek DJ, Schenkman KA, Ciesielski WA, Lee D, Conley KE (2005) Reduced mitochondrial coupling in vivo alters cellular energetics in aged mouse skeletal muscle. J Physiol 569:467\u2013473","journal-title":"J Physiol"},{"key":"10031_CR123","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10741-016-9593-0","volume":"22","author":"KJ Lavine","year":"2017","unstructured":"Lavine KJ, Sierra OL (2017) Skeletal muscle inflammation and atrophy in heart failure. Heart Fail Rev 22:179\u2013189","journal-title":"Heart Fail Rev"},{"key":"10031_CR124","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1161\/01.CIR.80.5.1338","volume":"80","author":"DM Mancini","year":"1989","unstructured":"Mancini DM, Coyle E, Coggan A et al (1989) Contribution of intrinsic skeletal muscle changes to 31P NMR skeletal muscle metabolic abnormalities in patients with chronic heart failure. Circulation 80:1338\u20131346","journal-title":"Circulation"},{"issue":"1","key":"10031_CR125","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13023-019-1006-8","volume":"14","author":"B Hornby","year":"2019","unstructured":"Hornby B, McClellan R, Buckley L, Carson K, Gooding T, Vernon HJ (2019) Functional exercise capacity, strength, balance and motion reaction time in Barth syndrome. Orphanet J Rare Dis 14(1):37","journal-title":"Orphanet J Rare Dis"},{"key":"10031_CR126","doi-asserted-by":"crossref","first-page":"7521","DOI":"10.1073\/pnas.89.16.7521","volume":"89","author":"MJ Kushmerick","year":"1992","unstructured":"Kushmerick MJ, Moerland TS, Wiseman RW (1992) Mammalian skeletal muscle fibers distinguished by contents of phosphocreatine, ATP, and Pi. Proc Natl Acad Sci U S A 89:7521\u20137525","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10031_CR127","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/(SICI)1099-1492(199602)9:1<8::AID-NBM387>3.0.CO;2-F","volume":"9","author":"H Takahashi","year":"1996","unstructured":"Takahashi H, Kuno SY, Katsuta S, Shimojo H, Masuda K, Yoshioka H, Anno I, Itai Y (1996) Relationships between fiber composition and NMR measurements in human skeletal muscle. NMR Biomed 9:8\u201312","journal-title":"NMR Biomed"},{"key":"10031_CR128","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10545-012-9486-x","volume":"36","author":"WT Cade","year":"2013","unstructured":"Cade WT, Spencer CT, Reeds DN, Waggoner AD, O\u2019Connor R, Maisenbacher M, Crowley JR, Byrne BJ, Peterson LR (2013) Substrate metabolism during basal and hyperinsulinemic conditions in adolescents and young-adults with Barth syndrome. J Inherit Metab Dis 36:91\u2013101","journal-title":"J Inherit Metab Dis"},{"key":"10031_CR129","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/apha.12307","volume":"213","author":"GJ Kemp","year":"2015","unstructured":"Kemp GJ, Ahmad RE, Nicolay K, Prompers JJ (2015) Quantification of skeletal muscle mitochondrial function by 31P magnetic resonance spectroscopy techniques: a quantitative review. Acta Physiol 213:107\u2013144","journal-title":"Acta Physiol"},{"key":"10031_CR130","first-page":"VI29","volume":"76","author":"K Wasserman","year":"1987","unstructured":"Wasserman K (1987) Determinants and detection of anaerobic threshold and consequences of exercise above it. Circulation 76:VI29\u2013VI39","journal-title":"Circulation"},{"key":"10031_CR131","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.bbadis.2013.03.005","volume":"1832","author":"F Gonzalvez","year":"2013","unstructured":"Gonzalvez F, D\u2019Aurelio M, Boutant M, Moustapha A, Puech JP, Landes T, Arnaun\u00e9-Pelloquin L, Vial G, Taleux N, Slomianny C, Wanders RJ, Houtkooper RH, Bellenguer P, M\u00f8ller IM, Gottlieb E, Vaz FM, Manfredi G, Petit PX (2013) Barth syndrome: cellular compensation of mitochondrial dysfunction and apoptosis inhibition due to changes in cardiolipin remodeling linked to tafazzin (TAZ) gene mutation. Biochim Biophys Acta 1832:1194\u20131206","journal-title":"Biochim Biophys Acta"},{"key":"10031_CR132","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nchembio.2113","volume":"12","author":"Y Xu","year":"2016","unstructured":"Xu Y, Phoon CK, Berno B, D\u2019Souza K, Hoedt E, Zhang G, Neubert TA, Epand RM, Ren M, Schlame M (2016) Loss of protein association causes cardiolipin degradation in Barth syndrome. Nat Chem Biol 12:641\u2013647","journal-title":"Nat Chem Biol"},{"key":"10031_CR133","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0022-510X(83)90209-5","volume":"62","author":"PG Barth","year":"1983","unstructured":"Barth PG, Scholte HR, Berden JA, Van der Klei-Van Moorsel JM, Luyt-Houwen IE, Van\u2019 t Veer-Korthof ET, Van der Harten JJ, Sobotka-Plojhar MA (1983) An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes. J Neurol Sci 62:327\u2013355","journal-title":"J Neurol Sci"},{"key":"10031_CR134","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.clnu.2008.05.007","volume":"27","author":"D Coman","year":"2008","unstructured":"Coman D, Yaplito-Lee J, Boneh A (2008) New indications and controversies in arginine therapy. Clin Nutr 27:489\u2013496","journal-title":"Clin Nutr"},{"key":"10031_CR135","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1750-1172-8-70","volume":"8","author":"C Rigaud","year":"2013","unstructured":"Rigaud C, Lebre AS, Touraine R, Beaupain B, Ottolenghi C, Chabli A, Ansquer H, Ozsahin H, Di Filippo S, De Lonlay P, Borm B, Rivier F, Vaillant MC, Mathieu-Dramard M, Goldenberg A, Viot G, Charron P, Rio M, Bonnet D, Donadieu J (2013) Natural history of Barth syndrome: a national cohort study of 22 patients. Orphanet J Rare Dis 8:70","journal-title":"Orphanet J Rare Dis"},{"key":"10031_CR136","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00431-007-0592-y","volume":"167","author":"TY Yen","year":"2008","unstructured":"Yen TY, Hwu WL, Chien YH, Wu MH, Lin MT, Tsao LY, Hsieh WS, Lee NC (2008) Acute metabolic decompensation and sudden death in Barth syndrome: report of a family and a literature review. Eur J Pediatr 167:941\u2013944","journal-title":"Eur J Pediatr"},{"key":"10031_CR137","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s00246-005-0873-z","volume":"26","author":"CT Spencer","year":"2005","unstructured":"Spencer CT, Byrne BJ, Gewitz MH, Wechsler SB, Kao AC, Gerstenfeld EP, Merliss AD, Carboni MP, Bryant RM (2005) Ventricular arrhythmia in the X-linked cardiomyopathy Barth syndrome. Pediatr Cardiol 26:632\u2013637","journal-title":"Pediatr Cardiol"},{"key":"10031_CR138","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s11897-012-0103-y","volume":"9","author":"JL Jefferies","year":"2012","unstructured":"Jefferies JL, Morales DL (2012) Mechanical circulatory support in children: bridge to transplant versus recovery. Curr Heart Fail Rep 9:236\u2013243","journal-title":"Curr Heart Fail Rep"},{"key":"10031_CR139","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1056\/NEJMoa1014164","volume":"367","author":"CD Fraser Jr","year":"2012","unstructured":"Fraser CD Jr, Jaquiss RD, Rosenthal DN, Humpl T, Canter CE, Blackstone EH, Naftel DC, Ichord RN, Bomgaars L, Tweddell JS, Massicotte MP, Turrentine MW, Cohen GQ, Devaney EJ, Pearce FB, Carberry KE, Kroslowitz R, Almond CS Berlin Heart Study (2012) Prospective trial of a pediatric ventricular assist device. N Engl J Med 367:532\u2013541","journal-title":"N Engl J Med"},{"key":"10031_CR140","doi-asserted-by":"crossref","first-page":"E46","DOI":"10.1111\/petr.12027","volume":"17","author":"N Dedieu","year":"2013","unstructured":"Dedieu N, Giardini A, Steward CG, Fenton M, Karimova A, Hsia TY, Burch M (2013) Successful mechanical circulatory support for 251 days in a child with intermittent severe neutropenia due to Barth syndrome. Pediatr Transplant 17:E46\u2013E49","journal-title":"Pediatr Transplant"},{"key":"10031_CR141","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1399-3046.2006.00629.x","volume":"11","author":"J Mangat","year":"2007","unstructured":"Mangat J, Lunnon-Wood T, Rees P, Elliott M, Burch M (2007) Successful cardiac transplantation in Barth syndrome-single-center experience of four patients. Pediatr Transplant 11:327\u2013331","journal-title":"Pediatr Transplant"},{"key":"10031_CR142","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1128\/JVI.77.6.3495-3504.2003","volume":"77","author":"BC Schnepp","year":"2003","unstructured":"Schnepp BC, Clark KR, Klemanski DL, Pacak CA, Johnson PR (2003) Genetic fate of recombinant adenoassociated virus vector genomes in muscle. J Virol 77:3495\u20133504","journal-title":"J Virol"},{"key":"10031_CR143","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13023-017-0605-5","volume":"12","author":"Y Huang","year":"2017","unstructured":"Huang Y, Powers C, Moore V, Schafer C, Ren M, Phoon CKL, James JF, Glukhov AV, Javadov S, Vaz FM, Jefferies JL, Strauss AW, Khuchua Z (2017) The PPAR pan-agonist bezafibrate ameliorates cardiomyopathy in a mouse model of Barth syndrome. Orphanet J Rare Dis 12:49\u201364","journal-title":"Orphanet J Rare Dis"},{"key":"10031_CR144","first-page":"654198","volume":"2014","author":"Q He","year":"2014","unstructured":"He Q, Harris N, Ren J, Han X (2014) Mitochondria-targeted antioxidant prevents cardiac dysfunction induced by tafazzin gene knockdown in cardiac myocytes. Oxidative Med Cell Longev 2014:654198","journal-title":"Oxidative Med Cell Longev"},{"key":"10031_CR145","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1161\/CIRCHEARTFAILURE.113.000406","volume":"6","author":"DF Dai","year":"2013","unstructured":"Dai DF, Hsieh EJ, Chen T, Menendez LG, Basisty NB, Tsai L, Beyer RP, Crispin DA, Shulman NJ, Szeto RH, Tian R, MacCoss MJ, Rabinovitch PS (2013) Global proteomics and pathway analysis of pressure overload-induced heart failure and its attenuation by mitochondrial-targeted peptides. Circ Heart Fail 6:1067\u20131076","journal-title":"Circ Heart Fail"},{"key":"10031_CR146","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1681\/ASN.2010080808","volume":"22","author":"HH Szeto","year":"2011","unstructured":"Szeto HH, Liu S, Soong Y, Wu D, Darrah SF, Cheng FY, Zhao Z, Ganger M, Tow CY, Seshan SV (2011) Mitochondria-targeted peptide accelerates ATP recovery and reduces ischemic kidney injury. J Am Soc Nephrol 22:1041\u20131052","journal-title":"J Am Soc Nephrol"},{"key":"10031_CR147","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1152\/japplphysiol.00471.2013","volume":"115","author":"EE Talbert","year":"2013","unstructured":"Talbert EE, Smuder AJ, Min K, Kwon OS, Szeto HH, Powers SK (2013) Immobilization-induced activation of key proteolytic systems in skeletal muscles is prevented by a mitochondria-targeted antioxidant. J Appl Physiol 115:529\u2013538","journal-title":"J Appl Physiol"},{"key":"10031_CR148","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1089\/ars.2009.2445","volume":"11","author":"L Yang","year":"2009","unstructured":"Yang L, Zhao K, Calingasan NY, Luo G, Szeto HH, Beal ME (2009) Mitochondria targeted peptides protect against 1-methy1-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. Antioxid Redox Signal 11:2095\u20132104","journal-title":"Antioxid Redox Signal"},{"key":"10031_CR149","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/1074248413508003","volume":"19","author":"DA Brown","year":"2014","unstructured":"Brown DA, Hale SL, Baines CP, del Rio CL, Hamlin RL, Yueyama Y, Kijtawomrat A, Yeh ST, Frasier CR, Stewart LM, Moukdar F, Shaikh SR, Fisher-Wellman KH, Neufer PD, Kloner RA (2014) Reduction of early reperfusion injury with the mitochondria-targeting peptide bendavia. J Cardiovasc Pharmacol Then 19:121\u2013132","journal-title":"J Cardiovasc Pharmacol Then"},{"key":"10031_CR150","doi-asserted-by":"publisher","unstructured":"Allen ME, Pennington ER, Perry JB, Dadoo S, Makrecka-Kuka M, Dambrova M, Moukdar F, Patel HD, Han X, Kidd GK, Benson EK, Raisch TB, Poelzing S, Brown DA, Shaikh SR (2020) Mitochondrial cristae networks in the post-ischemic heart: mitigation of ultrastructural and functional derangements with a cardiolipin-binding peptide. Nat Commun Biol 3(389). https:\/\/doi.org\/10.1038\/s42003-020-1101-3","DOI":"10.1038\/s42003-020-1101-3"},{"key":"10031_CR151","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1681\/ASN.2012121216","volume":"24","author":"AV Birk","year":"2013","unstructured":"Birk AV, Liu S, Soong Y, Mills W, Singh P, Warren JD, Seshan SV, Pardee JD, Szeto HH (2013) The mitochondrial-targeted compound SS-31 reenergizes ischemic mitochondria by interacting with cardiolipin. J Am Soc Nephrol 24:1250\u20131261","journal-title":"J Am Soc Nephrol"},{"key":"10031_CR152","doi-asserted-by":"crossref","first-page":"e002206","DOI":"10.1161\/CIRCHEARTFAILURE.115.002206","volume":"9","author":"HN Sabbah","year":"2016","unstructured":"Sabbah HN, Gupta RC, Kohli S, Wang M, Hachem S, Zhang K (2016) Chronic therapy with elamipretide (MTP-131), a novel mitochondria-targeting peptide, improves left ventricular and mitochondrial function in dogs with advanced heart failure. Circ Heart Fail 9:e002206","journal-title":"Circ Heart Fail"},{"issue":"2","key":"10031_CR153","first-page":"147","volume":"4","author":"KC Chatfield","year":"2019","unstructured":"Chatfield KC, Sparagna GC, Chau S, Phillips FK, Ambardekar AV, Aftab M, Mitchell MB, Sucharov CC, Miyamoto SD, Stauffer BL (2019) Elamipretide improves mitochondrial function in the failing human heart. JACC 4(2):147\u2013157","journal-title":"JACC"},{"key":"10031_CR154","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00109-014-1237-z","volume":"93","author":"MA Frohman","year":"2015","unstructured":"Frohman MA (2015) Role of mitochondrial lipids in guiding fission and fusion. Mol Med 93:263\u2013269","journal-title":"Mol Med"},{"key":"10031_CR155","doi-asserted-by":"crossref","first-page":"17589","DOI":"10.1074\/jbc.M111.330167","volume":"287","author":"AS Joshi","year":"2012","unstructured":"Joshi AS, Thompson MN, Fei N, Huttemann M, Greenberg ML (2012) Cardiolipin and mitochondrial phosphatidylethanolamine have overlapping functions in mitochondrial fusion in Saccharomyces cerevisiae. J Biol Chem 287:17589\u201317597","journal-title":"J Biol Chem"},{"key":"10031_CR156","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10557-018-6805-y","volume":"32","author":"HN Sabbah","year":"2018","unstructured":"Sabbah HN, Gupta RC, Singh-Gupta V, Zhang K, Lanfear DE (2018) Abnormalities of mitochondrial dynamics in the failing heart: normalization following long-term therapy with elamipretide. Cardiovasc Drugs Ther 32:319\u2013328","journal-title":"Cardiovasc Drugs Ther"},{"key":"10031_CR157","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1139\/cjpp-2014-0060","volume":"92","author":"S Givvimani","year":"2014","unstructured":"Givvimani S, Pushpakumar S, Veeranki S, Tyagi SC (2014) Dysregulation of Mfn2 and Drp-1 proteins in heart failure. Can J Physiol Pharmacol 92:583\u2013591","journal-title":"Can J Physiol Pharmacol"},{"key":"10031_CR158","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/cvr\/cvp181","volume":"84","author":"L Chen","year":"2009","unstructured":"Chen L, Gong Q, Stice JP, Knowlton AA (2009) Mitochondrial OPA1, apoptosis, and heart failure. Cardiovasc Res 84:91\u201399","journal-title":"Cardiovasc Res"},{"key":"10031_CR159","first-page":"141","volume":"148","author":"VG Sharov","year":"1996","unstructured":"Sharov VG, Sabbah HN, Shimoyama H, Goussev AV, Lesch M, Goldstein S (1996) Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure. Am J Pathol 148:141\u2013149","journal-title":"Am J Pathol"},{"key":"10031_CR160","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0033-0620(98)80003-0","volume":"40","author":"HN Sabbah","year":"1998","unstructured":"Sabbah HN, Sharov VG (1998) Apoptosis in heart failure. Prog Cardiovasc Dis 40:549\u2013562","journal-title":"Prog Cardiovasc Dis"},{"key":"10031_CR161","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1161\/CIRCRESAHA.118.312655","volume":"122","author":"SE Shires","year":"2018","unstructured":"Shires SE, Gustafsson AB (2018) Regulating renewable energy: connecting AMPKalpha2 to PINK1\/Parkin-mediated mitophagy in the heart. Circ Res 122:649\u2013651","journal-title":"Circ Res"},{"key":"10031_CR162","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cmet.2014.12.011","volume":"21","author":"M Song","year":"2015","unstructured":"Song M, Mihara K, Chen Y, Scorrano L, Dorn GW 2nd (2015) Mitochondrial fission and fusion factors reciprocally orchestrate mitophagic culling in mouse hearts and cultured fibroblasts. Cell Metab 21:273\u2013286","journal-title":"Cell Metab"},{"key":"10031_CR163","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1006\/jmcc.1998.0739","volume":"30","author":"VG Sharov","year":"1998","unstructured":"Sharov VG, Goussev A, Lesch M, Goldstein S, Sabbah HN (1998) Abnormal mitochondrial function in myocardium of dogs with chronic heart failure. J Mol Cell Cardiol 30:1757\u20131762","journal-title":"J Mol Cell Cardiol"},{"key":"10031_CR164","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1006\/jmcc.2000.1266","volume":"32","author":"VG Sharov","year":"2000","unstructured":"Sharov VG, Todor AV, Silverman N, Goldstein S, Sabbah HN (2000) Abnormal mitochondrial respiration in failed human myocardium. J Mol Cell Cardiol 32:2361\u20132367","journal-title":"J Mol Cell Cardiol"},{"key":"10031_CR165","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1161\/CIRCRESAHA.115.304384","volume":"115","author":"M Song","year":"2014","unstructured":"Song M, Chen Y, Gong G, Murphy E, Rabinovitch PS, Dorn GW 2nd (2014) Super-suppression of mitochondrial reactive oxygen species signaling impairs compensatory autophagy in primary mitophagic cardiomyopathy. Circ Res 115:348\u2013353","journal-title":"Circ Res"},{"key":"10031_CR166","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.yjmcc.2006.09.013","volume":"42","author":"VG Sharov","year":"2007","unstructured":"Sharov VG, Todor A, Khanal S, Imai M, Sabbah HN (2007) Cyclosporine A attenuates mitochondrial permeability transition and improves mitochondrial respiratory function in cardiomyocytes isolated from dogs with heart failure. J Mol Cell Cardiol 42:150\u2013158","journal-title":"J Mol Cell Cardiol"},{"key":"10031_CR167","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10741-005-7545-1","volume":"10","author":"VG Sharov","year":"2005","unstructured":"Sharov VG, Todor AV, Imai M, Sabbah HN (2005) Inhibition of mitochondrial permeability transition pores by cyclosporine A improves cytochrome C oxidase function and increases rate of ATP synthesis in failing cardiomyocytes. Heart Fail Rev 10:305\u2013310","journal-title":"Heart Fail Rev"},{"key":"10031_CR168","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0005-2728(93)90073-O","volume":"1140","author":"FN Gellerich","year":"1993","unstructured":"Gellerich FN, Khuchua ZA, Kuznetsov AV (1993) Influence of the mitochondrial outer membrane and the binding of creatine kinase to the mitochondrial inner membrane on the compartmentation of adenine nucleotides in the intermembrane space of rat heart mitochondria. Biochim Biophys Acta 1140:327\u2013334","journal-title":"Biochim Biophys Acta"},{"key":"10031_CR169","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.bbabio.2008.12.017","volume":"1787","author":"AP Halestrap","year":"2009","unstructured":"Halestrap AP, Pasdois P (2009) The role of the mitochondrial permeability transition pore in heart disease. Biochim Biophys Acta 1787:1402\u20131415","journal-title":"Biochim Biophys Acta"},{"key":"10031_CR170","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev.physiol.010908.163111","volume":"72","author":"RS Whelan","year":"2010","unstructured":"Whelan RS, Kaplinskiy V, Kitsis RN (2010) Cell death in the pathogenesis of heart disease: mechanisms and significance. Annu Rev Physiol 72:19\u201344","journal-title":"Annu Rev Physiol"},{"key":"10031_CR171","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.mito.2011.01.010","volume":"11","author":"M Huttemann","year":"2011","unstructured":"Huttemann M, Pecina P, Rainbolt M et al (2011) The multiple functions of cytochrome c and their regulation in life and death decisions of the mammalian cell: from respiration to apoptosis. Mitochondrion 11:369\u2013381","journal-title":"Mitochondrion"},{"key":"10031_CR172","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.yjmcc.2014.09.019","volume":"78","author":"Y Ikeda","year":"2015","unstructured":"Ikeda Y, Shirakabe A, Brady C, Zablocki D, Ohishi M, Sadoshima J (2015) Molecular mechanisms mediating mitochondrial dynamics and mitophagy and their functional roles in the cardiovascular system. J Mol Cell Cardiol 78:116\u2013122","journal-title":"J Mol Cell Cardiol"},{"key":"10031_CR173","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1161\/CIRCRESAHA.108.180869","volume":"103","author":"P Korge","year":"2008","unstructured":"Korge P, Ping P, Weiss JN (2008) Reactive oxygen species production in energized cardiac mitochondria during hypoxia\/reoxygenation: modulation by nitric oxide. Circ Res 103:873\u2013880","journal-title":"Circ Res"},{"key":"10031_CR174","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.ceca.2009.03.012","volume":"45","author":"G Paradies","year":"2009","unstructured":"Paradies G, Petrosillo G, Paradies V, Ruggiero FM (2009) Role of cardiolipin peroxidation and Ca2+ in mitochondrial dysfunction and disease. Cell Calcium 45:643\u2013650","journal-title":"Cell Calcium"},{"key":"10031_CR175","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1080\/10715760600918142","volume":"40","author":"ER Stadtman","year":"2006","unstructured":"Stadtman ER (2006) Protein oxidation and aging. Free Radic Res 40:1250\u20131258","journal-title":"Free Radic Res"},{"key":"10031_CR176","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ymeth.2010.02.020","volume":"51","author":"S Maynard","year":"2010","unstructured":"Maynard S, de Souza-Pinto NC, Scheibye-Knudsen M, Bohr VA (2010) Mitochondrial base excision repair assays. Methods 51:416\u2013425","journal-title":"Methods"},{"key":"10031_CR177","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1517\/14728220903039698","volume":"13","author":"I Andreadou","year":"2009","unstructured":"Andreadou I, Iliodromitis EK, Farmakis D, Kremastinos DT (2009) To prevent, protect and save the ischemic heart: antioxidants revisited. Expert Opin Ther Targets 13:945\u2013956","journal-title":"Expert Opin Ther Targets"},{"key":"10031_CR178","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/cvr\/cvv230","volume":"109","author":"KY Goh","year":"2016","unstructured":"Goh KY, Qu J, Hong H et al (2016) Impaired mitochondrial network excitability in failing Guinea-pig cardiomyocytes. Cardiovasc Res 109:79\u201389","journal-title":"Cardiovasc Res"},{"key":"10031_CR179","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1161\/01.RES.88.5.529","volume":"88","author":"T Ide","year":"2001","unstructured":"Ide T, Tsutsui H, Hayashidani S et al (2001) Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction. Circ Res 88:529\u2013535","journal-title":"Circ Res"},{"key":"10031_CR180","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1161\/01.RES.86.2.152","volume":"86","author":"T Ide","year":"2000","unstructured":"Ide T, Tsutsui H, Kinugawa S et al (2000) Direct evidence for increased hydroxyl radicals originating from superoxide in the failing myocardium. Circ Res 86:152\u2013157","journal-title":"Circ Res"},{"issue":"12","key":"10031_CR181","first-page":"e004389","volume":"10","author":"MA Daubert","year":"2017","unstructured":"Daubert MA, Yow E, Dunn G, Marchev S, Barnhart H, Douglas PS, O\u2019Connor C, Goldstein MDS, Udelson JE, Sabbah HN (2017) Novel mitochondria-targeting peptide in heart failure treatment. A randomized, placebo-controlled trial of elamipretide. Circulation 10(12):e004389","journal-title":"Circulation"},{"issue":"6","key":"10031_CR182","doi-asserted-by":"crossref","first-page":"e003118","DOI":"10.1161\/JAHA.115.003118","volume":"5","author":"A Eirin","year":"2016","unstructured":"Eirin A, Ebrahimi B, Hyo Kwon S, Fiala JA, Williams BJ, Woollard JR, He Q, Gupta RC, Sabbah HN, Prakash YS, Textor SC, Lerman A, Lerman LO (2016) Restoration of mitochondrial cardiolipin attenuates cardiac damage in swine renovascular hypertension. J Am Heart Assoc 5(6):e003118","journal-title":"J Am Heart Assoc"},{"key":"10031_CR183","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/ehf2.12408","volume":"6","author":"RC Gupta","year":"2019","unstructured":"Gupta RC, Singh-Gupta V, Zhang K, Sabbah HN, Gupta RC, Singh-Gupta V, Zhang K (2019) Effects of elamipretide on skeletal muscle in dogs with heart failure. ESC Heart Failure 6:328\u2013335","journal-title":"ESC Heart Failure"},{"key":"10031_CR184","doi-asserted-by":"crossref","first-page":"e1212","DOI":"10.1212\/WNL.0000000000005255","volume":"90","author":"A Karaa","year":"2018","unstructured":"Karaa A, Haas R, Goldstein A, Vockley J, Weaver DW, Cohen BH (2018) Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy. Neurology 90:e1212\u2013e1221","journal-title":"Neurology"},{"key":"10031_CR185","doi-asserted-by":"crossref","unstructured":"Thompson WR, Manuel, Aiudi A, Jones JJ, Carr J, Hornby B, Vernon HJ (2020) Elamipretide in patients with Barth syndrome: a randomized, double-blind, placebo-controlled clinical trial followed by 36-week open-label extension. Presented at: The American College of Cardiology Scientific Session 2020. March 28-30, Chicago","DOI":"10.1016\/S0735-1097(20)31584-9"},{"key":"10031_CR186","doi-asserted-by":"crossref","unstructured":"Thompson WR, Manuel, Aiudi A, Jones JJ, Carr J, Hornby B, Vernon HJ (2020) Elamipretide in patients with Barth syndrome: a randomized, double-blind, placebo-controlled clinical trial followed by a 36-week open-label extension. Presented at: 2020 Barth Syndrome Foundation Scientific and Medical Symposium. July 20-26, Clearwater","DOI":"10.1016\/S0735-1097(20)31584-9"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-020-10031-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-020-10031-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-020-10031-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T22:48:54Z","timestamp":1698187734000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-020-10031-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,1]]},"references-count":186,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["10031"],"URL":"https:\/\/doi.org\/10.1007\/s10741-020-10031-3","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,1]]},"assertion":[{"value":"21 September 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}